Ünal, Pelin
Lu, Ye
Bueno-de-Mesquita, Bas
van Eijck, Casper H. J.
Talar-Wojnarowska, Renata
Szentesi, Andrea
Gazouli, Maria
Kreivenaite, Edita
Tavano, Francesca
Małecka-Wojciesko, Ewa
Erőss, Bálint
Oliverius, Martin
Bunduc, Stefania
Nóbrega Aoki, Mateus
Vodickova, Ludmila
Boggi, Ugo
Giaccherini, Matteo
Kondrackiene, Jurate
Chammas, Roger
Palmieri, Orazio
Theodoropoulos, George E.
Bijlsma, Maarten F.
Basso, Daniela
Mohelnikova-Duchonova, Beatrice
Soucek, Pavel
Izbicki, Jakob R.
Kiudelis, Vytautas
Vanella, Giuseppe
Arcidiacono, Paolo Giorgio
Włodarczyk, Barbara
Hackert, Thilo
Schöttker, Ben
Uzunoglu, Faik G.
Bambi, Franco
Goetz, Mara
Hlavac, Viktor
Brenner, Hermann
Perri, Francesco
Carrara, Silvia
Landi, Stefano
Hegyi, Péter
Dijk, Frederike
Maiello, Evaristo
Capretti, Giovanni
Testoni, Sabrina Gloria Giulia
Petrone, Maria Chiara
Stocker, Hannah
Ermini, Stefano
Archibugi, Livia
Gentiluomo, Manuel
Cavestro, Giulia Martina
Pezzilli, Raffaele
Di Franco, Gregorio
Milanetto, Anna Caterina
Sperti, Cosimo
Neoptolemos, John P.
Morelli, Luca
Vokacova, Klara
Pasquali, Claudio
Lawlor, Rita T.
Bazzocchi, Francesca
Kupcinskas, Juozas
Capurso, Gabriele
Campa, Daniele
Canzian, Federico
Article History
Received: 9 November 2023
Accepted: 23 January 2024
First Online: 2 February 2024
Declarations
:
: MFB has received research funding from Celgene, Frame Therapeutics and Lead Pharma and has acted as a consultant to Servier. Other coauthors declare no conflict of interest.